Submission Details
| 510(k) Number | K251423 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 08, 2025 |
| Decision Date | February 06, 2026 |
| Days to Decision | 274 days |
| Submission Type | Traditional |
| Review Panel | Obstetrics & Gynecology (OB) |
| Summary | Summary PDF |
K251423 is an FDA 510(k) clearance for the Spectra S1 Pro; Spectra S2 Pro, a Pump, Breast, Powered (Class II — Special Controls, product code HGX), submitted by Uzinmedicare Co., Ltd. (Gyeonggi-Do, KR). The FDA issued a Cleared decision on February 6, 2026, 274 days after receiving the submission on May 8, 2025. This device falls under the Obstetrics & Gynecology review panel. Regulated under 21 CFR 884.5160.
| 510(k) Number | K251423 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 08, 2025 |
| Decision Date | February 06, 2026 |
| Days to Decision | 274 days |
| Submission Type | Traditional |
| Review Panel | Obstetrics & Gynecology (OB) |
| Summary | Summary PDF |
| Product Code | HGX — Pump, Breast, Powered |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 884.5160 |